Journals / Gülhane Tıp Dergisi / 2020 / Cilt: 62 - Sayı: 4

Comparison of vitamin D profile between patients with inflammatory and non-inflammatory rheumatic diseases

Pages
254–259
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: The results of this study are important in terms of routine monitoring and replacement of vitamin D in case of deficiency in chronic inflammatory and non-inflammatory rheumatic diseases presenting with pain.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: The aim of this study was to compare serum vitamin D levels in patients with inflammatory rheumatic diseases and non-inflammatory musculoskeletal disorders presenting with pain.
📊
Key Findings & Data:Group 1 consisted of patients with inflammatory rheumatic diseases; group 2, non-inflammatory musculoskeletal disorders; and group 3, healthy controls.
💡
Conclusion & Impact:Conclusions: The results of this study are important in terms of routine monitoring and replacement of vitamin D in case of deficiency in chronic inflammatory and non-inflammatory rheumatic diseases presenting with pain.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aims: The aim of this study was to compare serum vitamin D levels in patients with inflammatory rheumatic diseases and non-inflammatory musculoskeletal disorders presenting with pain. Methods: Patients were divided into three groups. Group 1 consisted of patients with inflammatory rheumatic diseases; group 2, non-inflammatory musculoskeletal disorders; and group 3, healthy controls. The plasma levels of 25(OH)D <10 ng/mL were accepted as vitamin D insufficiency. Correlation between pain intensity (visual analog scale), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) levels, disease activity score 28 (DAS28)-CRP for rheumatoid arthritis patients, Bath Ankylosing Spondylitis Disease Activity Index for ankylosing spondylitis patients, and 25(OH)D levels were analyzed. Results: Eighty-one patients with inflammatory rheumatic diseases (group 1, mean age=47.8±12.2 years), 26 patients with non-inflammatory musculoskeletal disorders (group 2, mean age=46.6±4.5 years), and 36 healthy controls (group 3, mean age=45.2±9.2 years) were included. There was a significant difference among the groups regarding 25(OH)D levels (group 1=16.4±11.3 ng/mL, group 2=13.9±6.4 ng/mL, group 3=20.4±8.2 ng/mL) (p=0.031). 25(OH)D levels in patients with non-inflammatory musculoskeletal diseases were lower than the healthy controls (p=0.003). No significant difference was seen between two patient groups (p=0.334). There was a weak-to-moderate negative correlation between pain intensity, ESR, CRP, DAS28-CRP and 25(OH)D levels (r=-0.302, p=0.002; r=-0.259, p=0.020; r=-0.259, p=0.020; r=-0.374, p=0.022 respectively). Conclusions: The results of this study are important in terms of routine monitoring and replacement of vitamin D in case of deficiency in chronic inflammatory and non-inflammatory rheumatic diseases presenting with pain.

🔖

Cite This Article

CÜZDAN, N., BENLİDAYI, İ. C., BAŞARAN, S., SARPEL, T. (2020). Comparison of vitamin D profile between patients with inflammatory and non-inflammatory rheumatic diseases. Gülhane Tıp Dergisi, Cilt: 62 - Sayı: 4, 254–259. https://ajindex.com/articles/225228

References (16)

  1. Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hypponen E. Vitamin D and chronic widespread pain in a white middle-aged british population: Evidence from a cross-sectional population survey. Ann Rheum Dis. 2009;68:817-822
  2. Lotfi A, Abdel-Nasser AM, Hamdy A, Omran AA, El-Rehany MA. Hypovitaminosis D in female patients with chronic low back pain. Clin Rheumatol. 2007;26:1895-1901
  3. Mouyis M, Ostor AJ, Crisp AJ, et al. Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology. 2008;47:1348-1351
  4. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78:1463-1470
  5. Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008;29:369-375
  6. Cutolo M. Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther. 2008;10:123
  7. Pelajo CF, Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010;9:507-510
  8. Haroon M, Bond U, Quillinan N, Phelan MJ, Regan MJ. The prevalence of vitamin D deficiency in consecutive new patients seen over a 6-month period in general rheumatology clinics. Clinical Rheumatology. 2010;30:789- 794
  9. Erten S, Kucuksahin O, Sahin A, Altunoglu A, Akyol M, Koca C. Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis. Intern Med. 2013;52:339-344
  10. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007;7:59-64
  11. Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012;3:181-187
  12. Grazio S, Naglić DB, Anić B, et al. Vitamin D serum level, disease activity and functional ability in different rheumatic patients. Am J Med Sci. 2015;349:46-49
  13. Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014;39:322-350
  14. Quraishi MK, Badsha H. Rheumatoid arthritis disease activity and vitamin D deficiency in an Asian resident population. Int J Rheum Dis. 2016;19:348-354
  15. Sahebari M, Mirfeizi Z, Rezaieyazdi Z, Rafatpanah H, Goshyeshi L. 25(OH) vitamin D serum values and rheumatoid arthritis disease activity (DAS28 ESR). Caspian J Intern Med. 2014;5:148-155
  16. Merlino LA, Curtis J, M